Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial
Naslov
Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial
Identifikator
/unibl/sci/idNaucniRad:24617
Tip
Pronađite slične unoseAcademic Article
Datum
Pronađite slične unose2018-08
Bibliografski citat
W. Park, LJ. Božić, D. Milakovic, A. Berrocal Kasay, E. El-Khouri, F. Irazoque-Palazuelos, F. Molina, P. Shesternya, P. Miranda, F. Medina-Rodriguez, Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial, Pubmed, pp. 934 - 943, Aug, 2018
Početna stranica
934
Krajnja stranica
943
Je dio
Pubmed
300104811